Search
Welcome
  • Login
  • Register
Forgot Password?
Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.
Not a subscriber? Subscribe here
Register Now
  • Login
  • Register
Forgot Password?
Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.
                       
Careers & Tenders
Newsletters
Subscribe
The Mail & Guardian
      SUBSCRIBE / Support independent journalism                   CAREERS & TENDERS / Visit careers.mg.co.za                   WHATSAPP? / Follow the M&G WhatsApp channel here            
Login / Register

LOGIN

  • News
    • Africa
    • Business
    • Editorial
    • Education
    • Health
    • Motoring
    • National
    • Sci-tech
    • Sport
    • World
  • Thought Leader
  • Politics
  • Green Guardian
  • Friday
  • Features
    • Buthelezi, the King’s Hand
    • Cabinet Report Cards 2023
    • Cabinet Report Cards 2012-2021
    • The Fiscal Cliff
  • Research World
    • Submissions
    • Papers
  • 200 Young South Africans
  • Events
    • 200 Young South Africans
    • Greening The Future
    • Power Of Women
      • 2024 Edition
    • Critical Thinking Forum
    • Youth Summit
    • Webinars
  • More..
    • Partners
    • Podcasts
    • Crossword
    • Digital Editions
    • Register
    • WhatsApp Channel
    • Login
    • Lost Password

           

ROCHE

High prices leave 10 000 breast cancer patients without life-saving treatment
National
/ 9 February 2022

High prices leave 10 000 breast cancer patients without life-saving treatment

The prices charged by health multinational Roche were ‘significantly out of kilter’, the Competition Commission found

By Sarah Smit
‘Roche holds cancer patients to ransom’ – activists
Article
/ 31 March 2016

‘Roche holds cancer patients to ransom’ – activists

Activists say if Roche does not drop the price of Herceptin, they will ask the health department to act.

By Mia Malan and Bhekisisa Team
No image available
Article
/ 25 August 2009

Roche defends diet drug as FDA probes liver claim

There is no evidence of a link between weight loss drug Xenical and liver injury, drugmaker Roche said on Tuesday.

By Staff Reporter

MAIL & GUARDIAN

ABOUT

About
Contact
Advertise

SUBSCRIPTIONS

Subscribe
Newsletters

FOLLOW

WhatsApp Channel
Twitter
Facebook
YouTube
Instagram
LinkedIn
TikTok
Threads

FLAGSHIP EVENTS

200 Young South Africans
Power Of Women
Greening The Future

LEGAL & CORRECTIONS

Privacy Policy
Cookie Policy
Ethics & Social Media Policy

RESOURCES

Mail & Guardian Careers
Property for sale


Mail & Guardian

© 2025 The Mail & Guardian. All rights reserved.

  • Login
  • Register
Forgot Password?
Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.
body::-webkit-scrollbar { width: 7px; } body::-webkit-scrollbar-track { border-radius: 10px; background: #f0f0f0; } body::-webkit-scrollbar-thumb { border-radius: 50px; background: #dfdbdb }